Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment

INTRODUCTION: More than 2 million individuals in the USA have an opioid use disorder (OUD). Methadone maintenance treatment is the gold standard of medication-based treatment for OUD, but high-dose methadone is associated with cardiotoxicity and respiratory complications, among other side effects. T...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open
Autors principals: Belcher, Annabelle M, Cole, Thomas O, Greenblatt, Aaron D, Hoag, Stephen W, Epstein, David H, Wagner, Michael, Billing, Amy S, Massey, Ebonie, Hamilton, Kristen R, Kozak, Zofia K, Welsh, Christopher J, Weintraub, Eric, Wickwire, Emerson M, Wish, Eric D, Kaptchuk, Ted J, Colloca, Luana
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2019
Matèries:
Addiction
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6596949/
https://ncbi.nlm.nih.gov/pubmed/31230007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-026604
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars